2000, Advocacy, Clinical Trials and Safety

Search:

DAY

WEEK

MONTH

YEAR

Select your country:
Sign up | Log in

2000

Advocacy

Clinical Trials

Safety

Paper: The transition of cannabis into the mainstream of Australian healthcare: framings in professional medical publications

Cannabis Law Report

NOVEMBER 24, 2021

However, the nature of the government regulations and the subsequent complexity of prescribing, as well as doctors’ safety uncertainties and the stigma of the plant, remain contributing barriers to patient access. Articles were sourced from the start of 2000 to the end of 2019. Data collection.

Research and Development

Research and Development Medicine Access Media

Psychedelic Invest’s 100 Most Influential People in Psychedelics List

Cannabis Law Report

JUNE 4, 2021

Rick, and MAPS, have published hundreds of research papers, articles, and reports over the past several decades in addition to participation in dozens of clinical trials and international studies. Originally a lawyer, Yang began working in startups and early stage growth companies as a founder or executive from 2000 to 2009.

Research and Development

Research and Development Medicine Treatment Pharmaceutical

Medical Cannabis Brief

Paper: The transition of cannabis into the mainstream of Australian healthcare: framings in professional medical publications

Psychedelic Invest’s 100 Most Influential People in Psychedelics List

Stay Connected